Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons

Cell Growth and Differentiation

Volumn 8, Issue 6, 1997, Pages 687-698

  Matikainen, Sampsa ^a   Ronni, Tapani ^a   Lehtonen, Anne ^a   Sareneva, Timo ^a   Melén, Krister ^a   Nordling, Stig ^b   Levy, David E ^c   Julkunen, Ilkka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; MESSENGER RNA; REGULATOR PROTEIN; RETINOIC ACID; STAT1 PROTEIN; STAT2 PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ACUTE-PHASE PROTEINS; BLOTTING, NORTHERN; BLOTTING, WESTERN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; LEUKEMIA, MYELOID; NEOPLASM PROTEINS; PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

ATRA;

EID: 0030972135     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Sen, G. C., and Ransohoff, R. M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res., 42: 57-102, 1993.
2. Muller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., Pellegrini, S., Wilks, A., Ihle, J. N., Stark, G. R., and Kerr, I. A. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature (Lond.), 366: 129-135, 1993.
3. Velazquez, L., Fellous, M., Stark, G. R., and Pellegrini, S. A protein tyrosine kinase in the interferon α/β signalling pathway. Cell, 75: 313-322, 1992.
4. Fu, X-Y., Kessler, D. S., Veals, S. A., Levy, D. E., and Darnell, J. E. ISGF-3, the transcriptional activator induced by interferon-α, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. USA, 87: 8555-8559, 1990.
5. Kessler, D. S., Veals, S. A., Fu, X-Y., Levy, D. E., and Darnell, J. E. Interferon-α regulates nuclear translocation and DNA-binding affinity of ISGF-3, a multimeric transcriptional activator. Genes Dev., 4: 1753-1765, 1990.
6. Fu, X-Y., Schindler, C., Improta, T., Aebersold, R., and Darnell, J. E. The proteins of ISGF-3, the interferon-α-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. USA, 89: 7840-7843, 1992.
7. Veals, S. A., Schindler, C., Leonard, D., Fu, X-Y., Aebersold, R., Darnell, J. E., and Levy, D. E. Subunit of an IFN-α-responsive transcription factor is related to IRF and Myb families of DNA binding proteins. Mol. Cell. Biol., 12: 3315-3324, 1992.
8. Schindler, C., Fu, X-Y., Improta, T., Aebersold, R., and Darnell, J. E. Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon-α. Proc. Natl. Acad. Sci. USA, 89: 7836-7839, 1992.
9. Schindler, C., Shuai, K., Prezioso, V. R., and Darnell, J. E. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science (Washington DC), 257: 809-813, 1992.
10. Schindler, C., and Darnell, J. E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem., 64: 621-651, 1995.
11. Ihle, J. N. STATs: signal transducers and activators of transcription. Cell, 84: 331-334, 1996.
12. Rutherford, M. N., Hannigan, G. E., and Williams, B. R. G. Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene. EMBO J., 7: 751-759, 1988.
13. Marie, I., Svab, J., Robert, N., Galabru, J., and Hovanessian, A. G. Differential expression and distinct structure of 69-and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J Biol. Chem., 265: 18601-18607, 1990.
14. Aebi, M., Fäh, J., Hurt, N., Samuel, C. E., Thomis, D., Bazzigher, L., Pavlovic, J., Haller, O., and Staeheli, P. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol. Cell. Biol., 9: 5062-5072, 1989.
15. Ronni, T., Melén, K., Malagin, A., and Julkunen, I. Control of IFN-inducible MxA gene expression in human cells. J. Immunol., 150: 1715-1726, 1993.
16. Ronni, T., Sareneva, T., Pirhonen, J., and Julkunen, I. Activation of IFN-α, IFN-γ, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol., 154: 2764-2774, 1995.
17. Melén, K., Keskinen, P., Ronni, T., Sareneva, T., Lounatmaa, K., and Julkunen, I. Human MxB protein, an IFN-α-inducible GTPase, contains nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J. Biol. Chem., 271: 23478-23486, 1996.
18. Shuai, K., Ziemiecki, A., Wilks, A., Harpur, A. G., Sadowski, H. B., Gilman, M. Z., and Darnell, J. E. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature (Lond.), 366: 580-583, 1993.
19. Silvennoinen, O., Ihle, J. N., Schlessinger, J., and Levy, D. E. Interferon-induced nuclear signalling by jak protein tyrosine kinase. Nature (Lond.), 366: 583-585, 1993.
20. Watling, D., Guschin, D., Muller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Rogers, N. C., Schindler, C., Stark, G. R., Ihle, J. N., and Kerr, I. M. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-y signal transduction pathway. Nature (Lond.), 366: 166-170, 1993.
21. Durbin, J. E., Hackenmiller, R., Simon, M. C., and Levy, D. E. Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell, 84: 443-450, 1996.
22. Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., and Schreiber, R. D. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell, 84: 431-442, 1996.
23. Rysiecki, G., Gewert, D. R., and Williams, B. R. G. Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res., 9: 649-657, 1989.
24. Hassel, B. A., Zhou, A., and Sotomayor, C. A. Dominant negative mutant of 2-5-A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J., 12: 3297-3304, 1993.
25. Meurs, E., Galabru, J., Barber, G. N., Katze, M. G., and Hovanessian, A. G. Tumor suppressor function of the interferon-induced double stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA, 90: 232-236, 1993.
26. Chong, K. L., Feng, L., Schappert, K., Meurs, E., Donahue, T. F., Friesen, J. D., Hovanessian, A. G., and Williams, B. R. G. Human p48 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J., 11: 1553-1562, 1992.
27. Harada, H., Kitakawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M., and Taniguchi, T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science (Washington DC), 259: 971-974, 1993.
28. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., and Taniguchi, T. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell, 77: 829-839, 1994.
29. Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., and Taniguchi, T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (Lond.), 376: 596-599, 1995.
30. Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., and Taniguchi, T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell, 58: 729-739, 1989.
31. Pine, R., Decker, T., Kessler, D. S., Levy, D. E., and Darnell, J. E. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both β interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol., 10: 2448-2457, 1990.
32. Lamphier, M., and Taniguchi, T. The transcription factors IRF-1 and IRF-2: linking the interferon response and cell growth control. The Immunologist, 2: 167-171, 1994.
33. Fujita, T., Reis, L. F. L., Watanabe, N., Kimura, Y., Taniguchi, T., and Vilcek, J. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second messenger pathways. Proc. Natl. Acad. Sci. USA, 86: 9936-9940, 1989.
34. Pine, R., Canova, A., and Schindler, C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91 gene. EMBO J. 13: 158-167, 1994.
35. Matikainen, S., Ronni, T., Hurme, M., Pine, R., and Julkunen, I. Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood, 88: 114-123, 1996.
36. Weiz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K., and Levi, B-Z. Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J Biol. Chem., 267: 25589-25596, 1992.
37. Nelson, N., Marks, M. S., Driggers, P. H., and Ozato, K. Interferon consensus-sequence binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene expression. Mol. Cell. Biol., 13: 588-599, 1993.
38. Cirelli, R., and Tyring, S. Major therapeutic uses of interferons. Clin. Immunother., 3: 27-87, 1995.
39. Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Valensi, F., and Berger, R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, 77: 1080-1086, 1991.
40. Harris, P., and Ralph, P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukocyte Biol., 37: 403-422, 1985.
41. Olsson, I. L., and Breitman, B. R. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic 3′,5′-monophosphate-inducing agents. Cancer Res., 42: 3924-3928, 1982.
42. Dalton, W. T., Ahearn, M. J., McCredle, K. B., Freireich, E. J., Stass, S. A., and Trujillo, J. M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood., 71: 242-247, 1988.
43. Uze, G., Lutfalla, G., and Gresser, I. Genetic transfer of a functional human interferon α receptor into mouse cells: cloning and expression of its cDNA. Cell, 60: 225-234, 1990.
44. Novick, D., Cohen, B., and Rubinstein, M. The human interferon α/β receptor: characterization and molecular cloning. Cell, 77: 391-400, 1994.
45. Lutfalla G., Holland, S. J., Cinato, E., Monneron, D., Reboul, J., Rogers, N. C., Smith, J. M., Stark, G. R., Gardiner, K., Mogensen, K. E., Kerr, I. M., and Uze, G. Mutant U5A cells are complemented by an interferon-α β receptor subunit generated by an alternative processing of a new member of a cytokine receptor gene cluster. EMBO J., 14: 5100-5108, 1995.
46. Domanski P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P., and Colamonici, O. R. Cloning and expression of a long form of the β subunit of the interferon α β receptor that is required for signaling. J. Biol. Chem., 270: 21606-21611, 1995.
47. Degos, L., Dombret, H., Chomienne, C., Daniel, M-T., Miclea, J-M., Chastang, C., Castaigne, S., and Fenaux, P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood, 85: 2643-2653, 1995.
48. Eisenhauer, E. A., Lippman, S. M., Cavanagh, J. J., Parades-Espinoza, M., Arnold, A., Hong, W. K., Massimini, G., Schleuniger, U., Bollag, W., Holdener, E. E., and Krakoff, I. Combination of 13-cis-retinoic acid and interferon α-2a in therapy of solid tumors. Leukemia (Baltimore), 8: 1622-1625, 1994.
49. Eilers, A., Seegert, D., Schindler, C., Baccarini, M., and Decker, T. The response of γ interferon activation factor is under developmental control in cells of the macrophage lineage. Mol. Cell. Biol., 13: 3245-3254, 1993.
50. Eilers, A., Georgellis, D., Klose, B., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., and Decker, T. Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages. Mol. Cell. Biol., 15: 3579-3586, 1995.
51. Kolla, V., Lindner, D. J., Weihua, X., Borden, E. C., and Kalvakolanu, D. V. Modulation of interferon (IFN)-inducible gene expression by retinoic acid. J. Biol. Chem., 271: 10508-10514, 1996.
52. Yan, R., Qureshi, S., Zhong, Z., Wen, Z., and Damell, J. E. The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2. Nucleic Acids Res., 23: 459-463, 1995.
53. Xu, B., Grander, D., Sangfelt, O., and Einhorn, S. Primary leukemia cells resistant to α-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3. Blood, 84: 1942-1949, 1994.
54. Cantell, K., Hirvonen, S., Kauppinen, H-L., and Myllylä, G. Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol., 78: 29-38, 1981.
55. Cantell, K., Hirvonen, S., and Kauppinen, H-L. Production and partial purification of human immune interferon. Methods Enzymol., 119: 54-63, 1986.
56. Larsen, J. K., Byskov, A. G., and Grinsted, J. Growth and differentiation of foetal mouse gonads in culture studied by flow cytometry on nuclear suspensions. In: O. D. Laerum, T. Lindmo, and E. Thornd, E. (eds.), Flow Cytometry IV, pp. 178-187. Oslo: Universitetsforlaget, 1980.
57. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biolocigally active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
58. Glisin, V., Crkvenjankov, R., and Byus, C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry, 13: 2633-2637, 1974.
59. Schwab, M., Alitalo, K., Varmus, H. E., Bishop, J. M., and George, D. A. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumor cells. Nature (Lond.), 303: 497-501, 1983.
60. Benech, P., Mory, Y., and Chebath, J. Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J., 4: 2249-2256, 1985.
61. Yang, X., Chung, D., and Cepko, C. L. Molecular cloning of the murine Jak1 protein tyrosine kinase and its expression in the mouse central nervous system. J. Neurosci., 13: 3006-3017, 1993.
62. Velazquez, L., Fellous, M., Stark, G., and Pellegrini, S. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell, 70: 313-322, 1992.
63. Andrews, N. C., and Faller, D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19: 2499, 1991.
64. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
65. Veals, S. A., Santa Maria, T., and Levy, D. E. Two domains of ISGFγ that mediate protein-DNA and protein-protein interaction during transcription factor assembly contribute to DNA-binding specificity. Mol. Cell. Biol., 13: 196-206, 1993.